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Abstract 
Opioid overdose is now the leading cause of unintentional injury related mortality in the U.S. 
with two people dying each day as a result of opioid overdose in Arizona. Among patients 
treated for opioid use disorder, chronic pain is frequently cited as the reason for opioid use.  
Treatment of chronic pain with long-term use of opioids is linked to increased medication 
tolerance, worsened pain sensitivity, and psychological symptoms. Acceptance of chronic pain is 
the individual’s ability to be willing to endure pain and their ability and willingness to participate 
in activities despite experiencing chronic pain. Increased acceptance of chronic pain has been 
shown to lower pain intensity, promote recovery of individuals’ emotional and physical abilities, 
and lessen use of pain medication including opioids.  Purpose: The purpose of this evidence-
based practice project was to examine the feasibility of using acceptance of chronic pain, pain 
severity, and pain interference as measures to evaluate the effectiveness of a multimodal 
residential treatment program for opioid abuse. Methods: Two surveys, the CPAQ and BPI were 
administered shortly after admission (T1) and after 21-25 days (T2) to evaluate project 
feasibility. Results: Six participants were enrolled. Three participants completed T1 and T2 
surveys. Three participants were lost to follow-up. Mean scores for Chronic Pain Acceptance 
were T1 = 79 (SD = 17.0) and T2 = 78.67 (SD = 5.0).  All surveys were easy to administer and 
participants answered all questions. Conclusion: Chronic pain acceptance may be a feasible and 
meaningful measure with which to evaluate residential treatment programs.  Further research is 
needed to evaluate acceptance of chronic pain with long-term opioid abstinence and overdose 
deaths.  
 keywords: chronic pain, chronic pain acceptance, residential, tailored treatment, opioid, 
opioid analgesic, opioid use disorder, mindfulness, medication assisted treatment 
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Evaluating the Effect of a Multimodal Residential  Program for Treatment of Opioid Use 
Disorder on Chronic Pain Acceptance: A Feasibility Project 
Introduction 
 Opioid overdose has increased at an alarming rate over the past decade with the Centers 
for Disease Control and Prevention (CDC) now calling it an epidemic. Between 1999 to 2014, 
165,000 opioid overdose deaths occurred with an increase of 21.4% opioid overdoses occurring 
between 2015 to 2016 (CDC, 2016; Scholl et al., 2018). In Arizona, two people die per day as a 
result of opioid overdose according to the Arizona Department of Health and Human Services 
(ADHS, 2018).  Drug overdose is now the leading cause of unintentional injury related mortality 
in the United States (Garcia et al., 2019).  
 Among patient populations treated for opioid use disorder (OUD), chronic pain is 
frequently cited as the reason for using illicit opioids (Mun et al., 2019). Chronic pain has an 
estimated prevalence of up to 116 million Americans (Pitcher et al., 2019). Chronic pain 
conditions have commonly been treated with opioid analgesia (OA), such as hydromorphone or 
morphine in the treatment of neuropathic pain (Stannard et al., 2015; Cooper et al., 2017). 
However, the treatment of chronic pain with long term use of OA is a significant factor in OUD 
(Kakko et al., 2018; VA/DoD, 2017). Studies show the treatment of chronic pain with long term 
use of OA is linked to increased medication tolerance, worsened pain sensitivity, and 
psychological symptoms (Stannard et al., 2015; Cooper et al., 2017; Kakko et al., 2018; Koller et 
al., 2019; VA/DoD, 2017). The CDC, Arizona Department of Health and Human Services 
(ADHS), and the Veterans Administration (VA/DoD), have issued clinical guidelines 
recommending that opioids not be prescribed for chronic pain but rather, that non-opioid 
pharmacological and non-pharmacological interventions be utilized. 
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Background and Significance 
Residential Treatment Programs 
 Residential treatment for OUD may improve non-completion of treatment and relapse 
due to increased structure and a more protected environment during treatment compared to 
outpatient settings (Stahler et al., 2016). The “gold standard” for OUD treatment programs, 
whether residential or outpatient, remains continued abstinence.  However, this measure is 
difficult to track over time. To evaluate treatment success, researchers often rely on completion 
of treatment program (Stahler et al., 2016) or overdose death rates post treatment (Morgan, et al. 
2020). 
Providing healthcare in the context of residential treatment programs for patients with 
OUD and chronic pain includes barriers, such as difficulties “to access therapy matched to 
[patients’] specific needs” (Kakko et al., 2018). Treatment of chronic pain in residential 
programs, for example, can be evaluated for patients’ pain acceptance scores, rather than pain 
intensity scores, to improve OUD outcomes. It has been shown that the severity of OUD for 
individuals with chronic pain in residential treatment may be worse with poor pain acceptance 
scores and not correlated with pain intensity scores (Lin et al., 2015).   Studies show that 
outcomes for chronic pain patients with OUD benefit most from “developing and introducing 
care pathways tailored to specific needs of the population” (Kakko et al., 2018). 
Chronic Pain 
Chronic pain is defined as “pain that typically lasts greater than 3 months or past the time 
of normal tissue healing” (CDC, 2016) and is characterized as a “complex human experience 
strongly influenced by psychosocial factors” (VA/DoD, 2017).  Chronic pain impacts the 
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individual’s functional ability and may significantly interfere with social and work activities 
(Kakko et al., 2018). 
While opioids effectively provide relief for acute pain, there has shown to be a worsening 
of pain in the setting of chronic pain (Kakko et al., 2018; Koller et al., 2019).  Opioid use has 
also been shown to cause psychological symptoms, insomnia, fatigue, and adverse cognitive 
reactions (Kakko et al., 2018). Additionally, prolonged use of OA has been found to cause 
medication tolerance, as well as hyperalgesia, or worsened pain sensitivity (Koller et al., 2019). 
Acceptance of Pain 
Acceptance of chronic pain is characterized as the individual’s ability to be willing to 
endure pain, as well as their ability to participate in activities, despite experiencing chronic pain 
(Kratz et al., 2018; Mun et al., 2019). For individuals with chronic pain, acceptance of chronic 
pain has been shown to lower pain intensity, promote recovery of individuals’ emotional and 
physical abilities, reduce depression, and improve their quality of life (Kratz et al., 2018).  
Studies have shown that patients with higher pain acceptance used less pain medications, 
including OA (Kratz et al., 2018). Studies also demonstrate a negative correlation between pain 
catastrophizing and pain acceptance, as well as a reduction in pain severity upon improved pain 
acceptance (Mun et al., 2019). Pain acceptance, rather than pain intensity, is a greater predictor 
for the individual’s participation in daily activities; a fundamental component of psychological 
and social wellness (Mun et al., 2019). While there is good evidence that acceptance of chronic 
pain among patients with OUD and chronic pain may be linked to less use of pain medications 
including opioids, no studies were found examining the effect of a multimodal program on 
acceptance of pain. Chronic pain acceptance may be a meaningful and feasible outcome measure 
to evaluate residential programs treating OUD in patients with chronic pain. 
6 
 
Problem Statement 
 There is a significant gap between published research and clinical practice in the 
treatment of individuals with OUD and chronic pain. There is strong evidence that interventions 
such as mindfulness, are effective in addressing both chronic pain and OUD. This led to the 
critical inquiry question: For individuals with OUD and chronic pain, do multimodal treatment 
plans improve chronic pain acceptance?  
Evidence Synthesis 
 A literature review was conducted to evaluate current evidence.  Three data bases, 
including Ebsco Host Academic Search Premier, PubMed, and PsychInfo were systematically 
searched using key terminology. Key terms searched included mindfulness, pain management, 
primary care, yoga, outcome, teaching, and education. Search criteria also included to sort for 
articles that were published in a peer-reviewed journal between 2014 to 2019 and in English.  
The Ebsco Host Academic Search Premier search results included 247 results for chronic 
pain (and) mindfulness, and 30 results for pain management (and) mindfulness (and) education. 
The PubMed search results included 233 results for pain management (and) mindfulness, and 50 
results for pain management (and) mindfulness (and) education. PsychInfo search results for 
chronic pain (and) mindfulness included 424 results, and 24 results for pain management (and) 
mindfulness (and) primary care. These results were evaluated for applicability to the clinical 
question. A total of ten articles were selected for this review, including two systematic reviews 
(SR) and eight random control trials (RCT). 
The ten studies were critically appraised within this review of evidence, including two SR 
and eight RCT (Appendix A). All studies included high level evidence, either level I or level II 
evidence, and with the exception of one study published in 2010, all studies were published 
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within the past 5 years. These studies used many questionnaire screening instruments to evaluate 
participants’ wellbeing pre and post mindfulness-based intervention. The screening tools 
specifically evaluated pre and post pain intensity, experience of chronic pain, mental health, 
functional ability, stress, coping, attitude, and perception of control (Appendix B). The evidence 
generated from the studies shows a variety of specific components of the participants well-being 
to nuance the individual’s multifaceted chronic pain experience in the context of a 
biopsychosocial issue rather than a pathophysiological complaint.  
The mindfulness interventions were similar across the studies and were designed in a 
manner that is highly applicable for the setting and population of patients with chronic pain in a 
residential setting. The mindfulness interventions are applicable given they are outpatient and 
designed for primary care providers to implement in the form of a referral for mindfulness 
education to impact patient outcomes. Most of the mindfulness interventions within the studies 
included are educational sessions with a trained mindfulness educator. Mindfulness interventions 
included the Mindfulness-based Stress Reduction (MBSR), Mindfulness Meditation (MM), 
Mindfulness- Oriented Recovery Enhancement (MORE), and Breathworks Program (Appendix 
B). 
Additional studies have been reviewed to update and add to information on the 
multimodal therapies to treat OUD.  An updated literature search was conducted using key words 
chronic pain (and)  pain acceptance.  An additional five articles were added regarding pain 
acceptance, including four high level evidence studies published within the past three years. The 
studies included a systematic review (Koller et al., 2019), a cross-sectional analysis (Kratz et al., 
2018), and two cohort studies (Kanzler et al., 2019; Mun et al., 2019). 
Pharmacological Therapies  
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             The CDC, ADHS, and VA/DoD have issued clinical guidelines for healthcare providers 
linking OA prescribing habits and the current opioid epidemic. There are increased guidelines 
addressing the appropriateness of OA use and emphasis on non-opioid pharmacological and non-
pharmacological interventions. OUD is a complex and multicausal issue that may stem from both 
prescribed and illicit opioid use.   
 Individuals with chronic pain and OUD may be treated with Medication-Assisted 
Treatment (MAT) medications, such as buprenorphine, methadone, and naltrexone, which are 
prescribed to treat OUD by reducing physical dependence symptoms, such as withdrawal or 
cravings (CDC, 2016). MAT medications may also have a therapeutic effect to treat pain, both 
acute as well as chronic. For patients with chronic pain receiving MAT who continue to 
experience chronic pain, treatment strategies, such as splitting doses, increasing the dosage, or 
changing medication between MAT medications have been shown to reduce chronic pain 
symptoms (Koller et al., 2019). 
However, despite practice guidelines and recommendations by the Department of 
Veterans Affairs, less than 35% of veterans were found to receive pharmacotherapy for OUD in 
2012 (Finlay et al., 2016). Finlay and colleagues (2018) found that across 97 residential 
programs studied, that the average rate of pharmacotherapy prescribed for OUD was 21% that in 
11 programs studied, none of the patients received pharmacotherapy for OUD. Reasons cited for 
lack of prescribing was prescribers’ lack of knowledge about appropriate pharmacotherapy for 
OUD and/or a philosophy against prescribing the medications. 
Integrative Therapies  
           Studies have suggested the use of integrative therapies, such as mindfulness, are 
associated with continued improvement of pain acceptance (Turner et al., 2016). Mindfulness is 
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characterized as “the awareness that emerges through purposeful non-judgmental attention to the 
present moment” (Turner et al., 2016). Mindfulness has been shown to improve chronic pain 
outcomes specifically,  acceptance of pain and decreased physical and emotional symptoms 
(Kratz et al., 2018; Turner et al., 2016). Evidence based mindfulness programs, such as 
Mindfulness-Based Stress Reduction (MBSR), Breathworks Mindfulness-Based Pain 
Management Programme, and Mindfulness-Oriented Recovery Enhancement (MORE), 
incorporate a variety of mindfulness techniques for chronic pain treatment into standardized 
programs (Cusens et al., 2010; Garland et al., 2014; Omidi et al, 2014; Turner et al., 2016). 
MBSR sessions include sitting meditation, body scan practice, breath focus exercise, raisin 
exercise to train being in the present moment, observing thoughts and feeling technique, as well 
as educational information on depression and the concept of acceptance (Omidi et al, 2014). In 
Breathworks, techniques also include breath-awareness, body-scan, mindful movement, kindly 
awareness, and mindfulness in daily life (Cusens et al., 2010). Similarly, MORE mindfulness 
techniques include mindful breathing, body scan, as well as attention to positive information 
(Garland et al., 2014).  
 Physiotherapy is another integrative therapy shown to improve chronic pain outcomes 
(Booth et al., 2017; USDHHS, 2019; Pedersen and Saltin, 2015). Patients with chronic pain who 
participated in physical therapy have outcomes shown to result in reduction of chronic pain, or to 
be pain free (Pullen, 2017).  The American Physical Therapy Association (APTA) clinical 
practice guidelines recommend evidence-based physical therapy interventions for individuals 
with chronic back pain.  Aerobic low intensity exercise therapy modalities and patient education 
especially have been shown to decrease pain for individuals with chronic pain (Hayden et al., 
2005). Evidence-based physical therapy patient education and counseling for the treatment of 
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chronic pain recommended in the APTA clinical guidelines includes anatomical and structural 
strength teaching, pain perception neuroscience, early resumption of activities of daily living, a 
goal setting for increasing activity levels rather than decreasing pain intensity  (Bier et al, 2017; 
Delitto et al., 2012).  
Internal Evidence 
 Internal evidence includes anecdotal discussions with executive leadership at the 
residential facility. The residential facility’s Nurse Practitioners report an estimated 25% 
prevalence rate of chronic pain in their patient population. In development of the treatment plan 
for patients with substance use disorder (SUD), addressing chronic pain per clinical guidelines 
contraindicate prescribing opioids (CDC, 2016).  A specific priority for the program is 
cultivating evidenced based non-pharmacological pain management practices that can be 
implemented to improve chronic pain syndrome outcomes. 
Theoretical Framework 
 The conceptual model used to guide this Doctorate of Nursing evidence-based practice 
project was the Acceptance and Commitment Therapy (ACT) Relational Frame Theory (RFT) 
(Appendix C). ACT was developed over 35 years ago to “promote behavioral effectiveness” 
(Hayes, 2019) rooted in RFT research (Barrett and McHugh, 2019) that “focuses on the context 
of an act and suggests the meaning of an act is directly related to its context, history, and 
purpose” (Knowlton et al., 2019).  ACT RFT has been studied frequently with transdiagnostic 
approaches and numerous chronic health condition management, such as chronic pain and 
headache, which are found to be some of the leading causes of disability throughout the world 
(Eysenbach et al., 2019; James et al., 2018; Lin et al., 2019). ACT promotes increased 
“psychological flexibility and workability in individuals via the acceptance of all private events 
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(thoughts, emotions, sensations, etc.,) cultivating present moment awareness and a stable sense 
of self, and clarifying and acting upon personal values—even in the presence of illness” (Karekla 
et al., 2019).  
 ACT targets six core processes with the goal of increasing psychological flexibility 
(Hayes et al., 2015). One of the six core processes is acceptance (Hayes et al., 2015). Acceptance 
is characterized through ACT as occurring “when an individual willingly experiences automatic, 
and sometimes unwanted, emotions or sensations without attempting to control the form, 
frequency or situational sensitivity of these experiences” (Zhang et al., 2018).  According to 
ACT, it appears increased pain acceptance improves both activity and disability (Kanzler et al., 
2019). Pain acceptance improves function regardless of pain severity (Kanzler et al., 2019; Lin et 
al., 2019). 
Evidence-Based Practice Framework 
Rosswurm and Larrabee’s (1999) evidence-based practice model was used to guide 
implementation of this project (Appendix D). Initial steps to apply this project included 
conversations with stakeholders in Arizona’s healthcare community, such as clinicians and 
government officials, to identify problems, issues, and gaps in current practice. Next, identifying 
multimodal treatment plans, such as mindfulness education, as a possible intervention with 
measurable outcomes. This led to a critical evaluation of current evidence in the SR and RCT 
studies, as well as the risks and benefits of implementation. With the evidence, the evidence-
based project was designed to evaluate multimodal treatment regarding acceptance of chronic 
pain.  The data collected was then analyzed. Lastly, the quality improvement project findings 
were then communicated to the clinic leadership to inform operations. 
Purpose 
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 The purpose of this project was to examine the feasibility of evaluating the effectiveness 
of a multimodal residential living program for residents with OUD and chronic pain using 
chronic pain acceptance, pain severity and interference to measure outcomes.  
Methods 
Ethics 
 Human subjects protection approval from the Arizona State University Institutional 
Research Board (IRB) was obtained on October 24, 2019. No demographic data was obtained as 
recommended by the IRB to maintain strict confidentiality with this highly vulnerable 
population. 
Setting 
 The project was conducted at an adult residential treatment facility, located in the 
metropolitan Phoenix, Arizona area. The facility focuses on the treatment of substance use 
disorders. Program goals are accomplished within the context of an interdisciplinary 
collaborative structure model involving three universities located in Arizona. The goal of this 
team-based interprofessional model is to positively address significant and local social issues. 
 Residents are evaluated by an admitting Nurse Practitioner (NP) and if needed, are 
provided with referrals to primary care providers in the local community for continuity of care 
upon discharge. During the resident’s stay, registered nurses are available to provide routine 
health maintenance assessments. Residents have access to psychiatric mental health care 
providers and may be prescribed non-opioid analgesic pharmaceuticals, antidepressants, as well 
as referred to a local MAT provider to evaluate and continue or initiate MAT. Additional 
services include social services, physical therapy, and occupational therapy.  Residents also have 
access to mindfulness education. 
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Population 
 The population included residents admitted to the facility who agreed to participate in the 
project. In addition to OUD, clients had to have a diagnosis of chronic pain as diagnosed by the 
admitting Nurse Practitioner, be able to speak and read English, and be age 18 years or older. 
Exclusion criteria included clients with a diagnosis of pain related to cancer or acute pain (pain 
that has lasted for less than three months.)    
Recruitment 
 Residents were evaluated by an admitting Nurse Practitioner at the facility’s corporate 
office intake who determined if an individual met eligibility criteria.  The admitting NP then 
notified non-clinical staff who gave eligible clients a flyer with project information and asked if 
they were interested in participating in the project.  Interested residents were then referred to the 
project manager.   
 The project manager met with potential participants to explain the project and answer any 
questions.  Residents who agreed to participate in the program were asked to complete two 
questionnaires measuring chronic pain acceptance and pain severity shortly after admission (T1) 
and to complete a second set of questionnaires after 21-25 days (T2). The second set of 
questionnaires consisted of the same surveys completed during T1 with the addition of a 
questionnaire created by the project manager asking about number and type of treatment sessions 
in which the patient participated during their stay.   
Instruments 
 The Chronic Pain Acceptance Questionnaire Revised (CPAQ-R) is a revised version of 
the original CPAQ developed in 1992 for individuals with chronic pain (McCracken et al., 
2004). The 20-question survey evaluates the individual’s overall pain acceptance and includes 
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two subscales measuring the individuals activity engagement defined as the pursuit of activities 
regardless of pain, and pain willingness, defined as the recognition by the individual that 
avoidance and control of pain may be not be effective methods of adapting to chronic pain 
(McCracken et al., 2006).  Studies have shown a correlation between participation in activity and 
willingness to endure pain as a predictor for how well the individual will adjust to chronic pain 
(Baranoff et al., 2014; la Cour and Peterson, 2015; McCracken et al., 2004; Turner et al, 2016; 
Vowles et al., 2008). The CPAQ-R uses a seven-point Likert scale for the patient to rate each of 
the 20 statements as never true (0) to always true (6) rating. Possible scores for total pain 
acceptance range from 0-140, activity tolerance range from 0-66, and pain willingness range 
from 0-54. Higher scores indicate higher levels of acceptance.  Studies have shown good to 
internal consistency with alphas of .82 for activity engagement and .78 for pain willingness. 
Validity has been demonstrated with moderate to high correlations with measures of avoidance, 
distress and daily functioning and predictive validity has been demonstrated by significant 
prediction of pain-related disability and distress using the CPAQ-R (McCracken et al., 2006).   
The Brief Pain Inventory (BPI) was developed for evaluating pain intensity and 
interference through an 11-item (0-10) Likert-scale. Pain severity is measured by the first four 
question and pain interference is measured by measuring seven components of the individual’s 
life affected by pain (Mun et al., 2019).  The BPI reliability and validity has been evaluated for 
patient populations with chronic nonmalignant pain and determined to be a recommended 
questionnaire (Tan et al., 2004). The first component was scored averaging the four pain severity 
questions. The pain severity questions use an 11-point Likert scale for the patient to rate each 
answer as no pain (0) to “pain as bad as you can imagine” (10) (Tan et al., 2004).  The second 
component of pain intensity was scored by averaging the seven questions for pain interference. 
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Possible scores for total pain interference range from 0-10, as well, with “does not interfere” (0) 
and “completely interferes (10) (Tan et al., 2004).  Higher scores indicate higher levels of pain 
severity and pain interference. 
 A therapy participation survey was created by the project manager to assess if clients 
participated in MAT, PT, OT or mindfulness education and to quantify participation.  The survey 
was self-report.  Answers were yes/no with a range of number of sessions for PT, OT, and 
mindfulness education sessions.  
Data collection  
 A master list was created by the project manager once clients agreed to participate in the 
project. The master list only contained participant names in order to follow-up with participants 
for the second data collection.  Participants created their own unique code number using the 
month and day from date of birth and the first three numbers of their phone number. All survey 
forms were identified only by the participant’s unique code. The master list did not include 
participant codes so that names and codes would not be linked. The master list was only stored 
on the project manager’s password protected USB device. Surveys completed by participants 
were scanned to the password protected USB device. Once each survey was scanned, it was 
immediately shredded.  Data entered were entered into an Excel spread sheet using unique 
participant codes. No names were entered into the database. The password protected USB device 
was stored in a locked container that was only accessed by the project manager at her home 
office. Upon completion of the project, the USB device was stored to be destroyed in May 2020 
by ASU IT personnel.  
 Time One (T1) data was collected within a few days of admission and Time Two (T2) 
data was collected 21-25 days after T1. Between T1 and T2, participants lived in the residential 
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treatment facility receiving treatment as usual (TAU). Information was disclosed to the facility 
administration in aggregate form only.  No names or other identifying information of participants 
was disclosed.  
Data analysis  
 Data was entered in an Excel file.  Data was analyzed using descriptive statistics. 
Inferential statistics were not performed due to small sample size.  
 
Results 
Participants 
 A total of six participants were consented.  All six participants completed all items of the 
initial CPAQ-R and BPI questionnaires.  Three participants were lost to follow up.  Three of the 
participants completed T2 CPAQ-R and BPI questionnaires, as well as the therapy participation 
survey. 
Acceptance of Chronic Pain 
 Chronic Pain Acceptance scores were obtained by summing the activity engagement and 
pain willingness scores (range = 0-140). Mean scores for Chronic Pain Acceptance were T1 = 79 
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(SD = 17.0) and T2 = 78.67 (SD = 5.0) (Table 1).  For the subscales, mean activity engagement 
scores increased slightly, T1 = 39 (SD = 19.3) and T2 = 45 (SD = 7.8). This was primarily due to 
one participant who had a score of 18 at T1 which increased to a score of 41 at T2. Pain 
willingness scores decreased slightly, T1 = 40 (SD = 4.0) and T2 = 33.67 (SD = 3.5).  
Pain Intensity and Pain Interference  
 Pain intensity and interference scores showed a slight improvement (Table 1).  Pain 
intensity scores decreased from T1 = 6.47 (SD = 1.8) and T2= 5.43 (SD = 2.3).  Pain interference 
scores also decreased from T1= 6.30 (SD = 0.8) and T2 = 5.42 (SD = 1.0). 
Therapy Participation 
 Of the three participants who completed T2 data, only one participant received MAT 
which was prescribed prior to admission.  None of the three participants reported receiving OT, 
PT, or attending mindfulness classes.   
Discussion 
 Due to the small sample size, no inferences can be made from this data.  Anecdotally, one 
participant’s score on the Activity Engagement scale improved from a score of 18 at T1 to a 
score of 41 at T2.  This individual did have higher pain intensity and pain interference scores 
than the mean scores at both T1 (7.25, 8.40) and T2 (6.25, 7.40) respectively. However, there 
was no improvement for any of the participants on pain willingness. 
 Unexpectantly, while one of the participants did receive MAT, none of the participants 
reported receiving PT, OT, or participating in mindfulness education. It is unknown if this was 
underreported by participants, if participants declined the therapy, or whether participants were 
not aware of, or not offered these treatment modalities.  
Project Strengths  
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 Selected instruments were well supported by current literature. Participants were able to 
complete surveys within 30 minutes.  This was important as participants were known to have 
significant levels of chronic pain and suffering from OUD. Participants did not seem to have 
difficulty with any of the survey items and answered all questions on each survey. Additionally, 
organization administration and staff were supportive of the project. 
Limitations and Opportunity for Improvement 
 The greatest limitation was the small sample size. This may have been because 
recruitment and data collection occurred primarily during the holidays in November and 
December. During the month of January, there was also a decreased number of physical therapy 
students on site because of semester break.  Additionally, data collection was terminated in early 
March due to the COVID-19 pandemic.  
 Other limitations included an inconsistent process of recruiting participants and obtaining 
T2 data.  Additionally, the therapy participation survey did not include an option for clients to 
report if they were aware of or why they did not participate in a specific treatment modality.  
Implications and Recommendations for Future Study 
 It is feasible to use chronic pain acceptance as measured by the CPAQ-R and pain 
intensity and interference as measured by the BPI for evaluating treatment effectiveness in the 
residential setting.  In the future, a longer period of time is recommended to collect data and 
strategies for recruitment and follow-up need to be improved.  The Therapy Participation survey 
should also be revised to include a more nuanced description of treatment modalities to clarify if 
participants declined services, were unaware of, or not offered treatments.  
Conclusion 
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 Research supports that higher levels of acceptance of chronic pain are associated with 
lower pain intensity, increased emotional and physical ability, reduced depression, and decreased 
use of pain medication, including opioids.  No studies of residential opioid treatment facilities 
were found that used pain acceptance as an outcome measure to evaluate programs.  Studies 
relied primarily on program completion or overdose death as outcome measures.  This project 
provides beginning data on the feasibility of using acceptance of chronic pain and pain severity 
and interference to evaluate residential treatment program effectiveness.  Further research is 
needed to evaluate acceptance of pain with long-term opioid abstinence and overdose deaths. 
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Setting: 
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Group Health 
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groups/week x 8 
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Inclusion: Age 
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Conclusions:  
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Informs regarding 
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Funding:  
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analysis 
 
Purpose: 
Analyze 
relationship 
between 
disposition-
al Mi and 
rx OpM 
among 
opioid 
treated CP 
pts. 
 
N= 300 
n=3 
 
S1: 115 
S2: 141 
S3: 44 
 
Demographics: 
S1:  
M age 48.3,  
f- 68% 
S2:  
M age 51.3,  
f-62.7% 
S3:  
M age 33,  
f-11.4% 
 
 
IV: Pts with 
CP OpM 
 
DV: Evaluation 
of pt Mi 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMM, FFMQ, 
APNIS, BPI 
 
SPSS, 
Pearson 
correlation, 
path 
analysis. 
COMM r = 
-0.36 
p value - 
0.001 
 
 
Level of Evidence: 
I 
 
Strengths: 
Systematic review 
cross-sectional 
analysis 
 
Weaknesses: S3 
smaller sample size. 
 
Harm: None 
 
Conclusions: 
Dispositional Mi 
inverse relationship 
w/ OpM  
 
Utility to PICOT: 
Supports Mi 
intervention for CP 
treatment. 
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
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Ball, E. F., et al., 
(2017). Does  
MM improve 
CP? A 
systematic 
review.  
 
Country: U.K. 
 
Funding: Rod 
Flower Vacation 
Scholarship 
 
Conflicts/Bias: 
None 
MMT Design: 
Systematic 
Review 
Meta-
Analysis 
 
Purpose: 
Eval 
Mi to 
mitigate 
CP 
 
n= 13 RCT 
N= 862 
 
Demographics: 
Female/male 
1. 40/17 
2. 22/17 
3. 33/7 
4. 23/7 
5. 91/0 
6. 21/16 
7. 15/5 
8. 177/0 
9. 23/7 
10. 93/16 
11. 26/16 
12. 112/12 
13. 19/0 
 
Meta-analysis 
SG: 
SG1 n= 183 
SG2 n= 183 
SG3 n= 374 
IV: 
Mindfulness 
program 
 
SG1: affective 
pain 
SG2: sensory 
pain 
SG3: pain 
intensity 
SG4: pain 
acceptance 
SG5:  dep 
SG6: anx 
SG7: mental 
QOL 
SG8: physical 
QOL 
 
DV:  
UC 
 
 
 
Unspecified Forest plots, 
Meta-
analysis 
with 
random 
effect 
model, 
Review 
Manager 
5.3, Funnel 
plots  
Improved  
SG1: SMD        
-0.13  
Improved  
SG2: SMD       
-0.02  
Improved  
SG3: SMD  
0.14 
Improved  
SG4: SMD 
0.34 
Improved  
SG5: SMD 
 -0.31 
Improved  
SG6: SMD  
-0.21  
Improved  
SG7: SMD 
0.04  
Improved  
SG8: SMD 
0.57 
Level of Evidence: 
I 
 
Strengths:  
Meta-analysis of 13 
RCTs 
 
Weaknesses: 
Unspecified 
instruments; gender 
 
Harm: None 
 
Conclusions: 
Effective most for 
dep. Effective for 
anx, affective pain, 
sensory pain, 
mental and physical 
QOL. 
 
Utility to PICOT: 
Consistent findings; 
Significant 
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
SG4 n= 251 
SG5 n= 368 
SG6: n=278 
SG7: n= 193 
SG8: n=230 
SG9: n=215 
 
supportive evidence 
for practice 
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Method/ 
Purpose 
Sample/Setting Major 
Variables 
Studied and 
Their 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
Findings/ 
Results 
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Cusens, B., et 
al., (2010). Eval 
of the 
Breathworks  
Mi pain 
management 
programme: 
Effects on well-
being and 
multiple 
measures of Mi.  
 
Country: U.K. 
 
Funding: 
Unspecified 
 
Conflicts/Bias: 
None 
MMT; 
Buddhist 
foundation 
‘loving 
kindness’ 
Design: 
Pilot 
program 
eval 
  
Purpose:  
Eval 
Breath-
works 
programme 
N= 53 
IG: 33 
CG: 20 
 
Demographics: 
IG: 
CR-95% 
F-93% 
M age-46.7 
 
CG: 
CR-89% 
F-55% 
M age-48.4 
 
Inclusion: 
Students of 
Breathworks 
Pain 
Management 
DV:  
Breathworks 
programme 
 
Breathworks 
programme: 
Weekly 2.5 
hour meeting 
teaching on Mi; 
breath-
awareness, 
body-scan, 
mindful 
movement, 
kindly 
awareness. 
 
 
 
 
 
DAPOS, CPAQ, 
PSEQ, PCS, 
SF36 
2x2 mixed 
factors 
design, 
parametric 
tests, 
Huberty 
and Morris, 
ANOVA  
Improved 
pain 
acceptance, 
increased 
awareness 
pleasant 
affect. 
 
Level of Evidence: 
IV 
 
Strengths: 
Application of 
program 
 
Weaknesses: Small 
number 
participants; LOE 
 
Harm: None 
 
Conclusions:  
Evidence to support 
immediate effects 
of MBSR 
 
Utility to PICOT: 
PCP setting 
implementation 
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
Programme who 
signed consent 
forms; 
Outpatient pain 
clinic support 
group who opted 
in. 
 
Exclusion: 
Unspecified 
 
 
 
 
 
 
feasible, prompt f/u 
results  
Citation Theory/ 
Conceptual 
Framework 
Design/ 
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Purpose 
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Analysis 
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Results 
Level of evidence/ 
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Garland, E. L., 
et al. (2014). Mi-
oriented 
recovery 
enhancement for 
CP and 
prescription 
OpM: Results 
from an early-
stage RCT.  
 
Country: U.S. 
 
Funding: The 
National 
Institute on Drug 
Abuse; Fahs-
Beck Fund for 
MMT Design:  
RCT 
 
Purpose:  
Eval 
MORE 
effect on 
CP and 
OpM 
compared 
to UC 
N= 115 
 
Demographics: 
M age 48 
 f-68% 
 
Inclusion: Pain, 
treated with 
opioids 
 
Excluded: 
Comorbid 
psychiatric 
disorder 
IV: Group with 
UC screened 
with 
instruments 
 
DV:  
MORE 
 
MORE: Int 
multi-modal 
training w/ Mi 
training, 
positive 
emotion 
regulation, 
reappraisal of 
thinking. 
 
BPI, COMM, 
FFMQ, CSQ, 
CERQ, C-SOSI, 
ATT 
ANCOVA, 
ITT,  X2 
test, t tests, 
Cohen’s d, 
G*Power 
software 
3.1.  
Good 
effect for 
CP and 
OpM 
reduction 
 
Level of Evidence: 
II 
 
Strengths: RCT 
 
Weaknesses:  
Setting of opioid 
ongoing 
 
Harm: None 
 
Conclusions:  
Mi reduces CP 
 
Utility to PICOT: 
Evidence 
supporting Mi 
reducing CP, 
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
Research and 
Experimentation 
 
Conflicts/Bias: 
None 
 
 
 
 
 
 
 
 
 
decreased opioid 
use 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting Major 
Variables 
Studied and 
Their 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
Findings/ 
Results 
Level of evidence/ 
Decision for 
Use/Application to 
Practice 
Sharon, H., et 
al., (2016). MM 
modulates pain 
through 
endogenous 
opioids.  
 
Country: Israel 
 
Funding: I-
CORE Program 
of the Budgeting 
Committee; The 
Israel Science 
Foundation 
 
Conflicts/Bias: 
None 
MMT Design: 
RCT 
 
Purpose:  
Eval pain 
caused by 
hand in ice 
water 
pre/post 
meditation 
session w/ 
and w/out 
naloxone 
N= 15 
 
Demographics: 
Unspecified; 
healthy 
mindfulness 
practitioners 
 
Exclusion:  
CP, neuro 
disease, 
psychiatric 
disorder  
 
Attrition: 1 
 
IV: MM 
session 
 
DV: MM 
session with 
administered 
naloxone 
 
 
 
 
 
 
 
 
 
 
 
VAS 3x2 
repeated 
measures, 
post hoc, 
Tukey. 
Pain 
reduced 
post MM; 
Naloxone 
reversed 
pain relief. 
 
Level of Evidence: 
II 
 
Strengths: RCT 
 
Weaknesses:  
Unspecified 
demographics. 
Unnamed 
instrument for 
unpleasantness 
measurement.  
Small # of parts. 
 
Harm: None 
 
Conclusions:  
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
Mi reduces pain; 
Mi creates 
endogenous opioids 
 
Utility to PICOT: 
Evidence to support 
Mi  reduces pain 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting Major 
Variables 
Studied and 
Their 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
Findings/ 
Results 
Level of evidence/ 
Decision for 
Use/Application to 
Practice 
Omidi, A., & 
Zargar, F. 
(2014). Effect of 
MBSR on pain 
severity and 
mindful 
awareness in 
patients with 
tension 
headache: a 
randomized 
controlled 
clinical trial.  
 
 
Country: Iran 
 
Funding: 
Unspecified 
 
MMT Design:  
RCT 
 
Purpose:  
Eval 
MBSR 
effect on 
patients 
with 
tension 
headache 
pain 
severity, 
perceived 
stress, 
general 
mental 
health, and 
Mi skills  
 
N= 66 
 
Demographics: 
IG: 
M age 34.5 
CG: 
M age 32 
IV: Group with 
UC eval with 
instruments 
 
DV: MBSR 
 
 
 
 
 
 
 
 
 
 
 
MAAS, Pain 
scale 
Repeated 
measures 
analysis of 
variance, X2 
test 
Reduced 
pain, 
improved 
MAAS 
scores post 
MBSR 
 
Level of Evidence: 
II 
 
Strengths:  
RCT 
 
Weaknesses: 
Limited data on 
bias or funding. 
 
Harm: None 
 
Conclusions:  
MBSR reduces pain 
intensity 
 
Utility to PICOT: 
MBSR reduces pain  
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
Conflicts/Bias: 
Unspecified 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting Major 
Variables 
Studied and 
Their 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
Findings/ 
Results 
Level of evidence/ 
Decision for 
Use/Application to 
Practice 
Zgierska, et al.,  
(2016). MM and 
CBT Int reduces 
pain severity and 
sensitivity in 
opioid-treated 
CLBP: Pilot 
findings from a 
RCT.  
 
Country: U.S. 
 
Funding: 
Unspecified 
 
Conflicts/Bias: 
None 
MMT Design:  
RCT 
 
Purpose:  
Eval effect 
MM with 
CBT effect 
on pain 
severity, 
sensitivity 
for CLBP 
N= 35 
IG: 14 
CG: 21 
 
Demographics: 
Unspecified 
 
Inclusion: 
CLBP treated 
with opioid > 90 
days 
 
Exclusion: 
Age under 21, 
non-English 
speaking, 
pregnancy, 
severe psych 
IV: UC group 
eval with 
instruments 
 
DV: 
Meditation-
CBT Int 
 
 
Meditation 
CBT Int: 
8 weeks of 2 
hour classes 
weekly 
conducted by 
psychologists 
 
 
 
 
 
 
 
 
 
BPI, CPAQ, 
MAAS, ODI, 
PSS 
Mann-
Whitney – 
Wilcoxon 
Test, 
Cohen’s d, 
Spearman 
correlations 
Improved 
pain 
severity 
and 
sensitivity 
post MM 
with CBT 
 
Level of Evidence: 
II 
 
Strengths: RCT 
 
Weaknesses: Study 
was not blinded 
 
Harm: None 
 
Conclusions:  
Effective to treat 
CLBP within two 
months 
 
Utility to PICOT: 
Feasible for PCP 
setting, prompt 
results.  
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
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M age 50 
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AA – African American, Anx- Anxiety, API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, AS: Asian, ATT- Attitudes Toward Treatment, b/w – between,– BP- back 
pain, BPI–Brief Pain Inventory, C-SOSI- Calgary Symptoms of Stress Inventory, CBT–Cognitive-behavioral therapy, CERQ—Cognitive Emotion Regulation Questionairre, CG- Control group, CI – Confidence interval, 
CLBP–Chronic low back pain, Co: coupled or married, COMM–Current Opioid Misuse Measure, Commu – Communication, CP- chronic pain, CPAQ–Chronic Pain Acceptance Questionnaire, CR – Caucasian race, CSQ–
Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, Dep- Depression, DV1 – Dependent variable 1, DV2 – Dependent variable 2, Em: Employed, ES – Educational session, Eval – 
Evaluation, f – female, FA - Functional ability, FFMQ–Five Facet Mindfulness Questionnaire, FL - Functional limitation, FS – Functional status, F/U – Follow Up, GAD–Generalized Anxiety Disorder scale, GCPS–Graded 
Chronic Pain Scale, H – Hispanic, HADS–Hospital Anxiety and Depression Scale, IG- Intervention group, Int- Intervention, Inv- Investigate, ITT–Intent to Treat, IV – Independent variable, m – Male, M –Mean, MAAS—
Mindfulness Attention Awareness Scale, MAP–Mind-Body Approaches to Pain, MBI–Mindfulness-based interventions, MBSR–Mindfulness-based stress reduction, Med- Medication, Mi- Mindfulness, MM- Mindfulness 
meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire,  N – Sample (population), n – Sample size (studies), OCRS-R–
Obsessive-Compulsive Drug Use Scale, ODI—Oswestry Disability Index, OpM- Opioid Misuse, OS – Observational Study, PCP– Primary care provider, PCS–Pain Catastrophizing Scale, PE - Patient education, PGIC–The 
Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— Perceived Stress Scale, Pt – Participant, QOL – Quality of life, Quest – Questionnaire, RCT – 
Randomized Controlled Trial,, S1: study group one, S2: study group two,  S3: study group three, SD – Standard deviation, SF12–Short-Form Health Survey 12, SF36–Short-Form Health Survey 36, SMD- Standardized Mean 
Difference SPSS - Statistical Package for the Social Sciences, UC- usual care, w/ - with, X2 – Chi square, Yrs – years, # - Number of 
Inclusion: Age 
20-70, CBP, pain 
level >3. 
 
Exclusion: 
Pregnancy, non-
English 
speaking, 
previous mind-
body treatment  
education on 
CP, coping 
skills 
 
Variables: 
catastrophizing, 
self-efficacy, 
acceptance 
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API–Attention to Positive Information Score, APNIS–Attention to Positive and Negative Information Score, ATT- Attitudes Toward Treatment, BPI–Brief Pain 
Inventory, CERQ—Cognitive Emotion Regulation Questionairre, C-SOSI- Calgary Symptoms of Stress Inventory, CPAQ–Chronic Pain Acceptance 
Questionnaire, CSQ–Coping Strategies Questionnaire, DAPOS— Depression Anxiety and Positive Outlook Scale, FFMQ–Five Facet Mindfulness Questionnaire, 
GAD–Generalized Anxiety Disorder scale, GCPS–Graded Chronic Pain Scale, HADS–Hospital Anxiety and Depression Scale, MAAS—Mindfulness Attention 
Awareness Scale, MBSR–Mindfulness-based stress reduction, MM- Mindfulness meditation, MMT–Mindfulness-to-meaning theory, MORE- Mindfulness- 
Oriented Recovery Enhancement, MRDQ–Modified Roland Disability Questionnaire, ODI—Oswestry Disability Index,  Part- Participants, PCS–Pain 
Catastrophizing Scale, PGIC–The Patient Global Impression of Change Scale, PHQ–Patient Health Questionnaire, PSEQ–Pain Self-Efficacy Questionnaire, PSS— 
Perceived Stress Scale, QOL – Quality of life, RCT – Randomized Controlled Trial, SF–Short-Form Health Survey ↓ - Reduced, ↑ - Increased 
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Year 2017 2016 2010 2014 2015 2014 2018 2016 2016 2016 
Design/LOE SR RCT RCT RCT RCT RCT SR RCT RCT RCT 
# Pts/ Studies 862/13  342 53 115 109 66 300/3 15 342 35 
M
ea
su
re
m
en
ts
/ 
In
st
ru
m
en
ta
ti
o
n
 
BPI/PS 
 
 x x x x x x  x 
SF/ODI/ MRDQ/RDQ x x  x    x  
HADS/PHQ/GAD/ 
DAPOS 
x x  x    x  
CSQ   x x      
PGIC x         
FFMQ/APNIS/API/ 
MAAS/CERQ 
 x x  x x  x x 
PSEQ/PCS/ 
GCPS/CPAQ 
x x x x    x x 
C-SOSI/ PSS   x      x 
In
te
rv
en
ti
o
n
s MBSR  x   x x x  x  
Breathworks   x        
MORE    x       
MM        x  x 
MBM x          
M
a
jo
r 
fi
n
d
in
g
s 
 
Pain Intensity ↓ 
 
↓ 
 
 
↓ 
 
↓ 

↓ 

 
↓ 

 
↓ 

Pain Control/ 
Acceptance 
  
↑
 
 
↑
 
   
↑
 
 
QOL ↑
 
   
↑
 
     
Functional Ability 
 
↑
 
 
↑
 
↑
 
     
Anxiety ↓ 
 
   
↓ 
 
     
Depression ↓ 
 
↓ 
 
↓ 
 
 
↓ 
 
     
Applicability x x x x x x x x x x 
                                                              Appendix B 
Table 3 
 
Synthesis Table 
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Note: Acceptance and Commitment Therapy (ACT) Relational Frame Theory (RFT), (Hayes et 
al., 2015). 
Appendix C 
Figure 1 
 
Conceptual Model 
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Appendix D 
Figure 2 
 
Evidence Based Model 
Note: Rosswurm and Larrabbee Model (1999). 
 
